DEA decides to make CBDs and cannabis extracts a Schedule 1

The DEA has placed CBDs and cannabis extracts in the Schedule 1 drug category

  • Anybody living in a state with no medicinal or recreational cannabis laws will no longer have access to CBDs and extracts

  • Licensed cannabis handlers have 30-days to refile their paperwork to include CBDs and extracts

  • CBDs are primarily used for medicinal purposes known for helping with the treatment of seizures

The cannabis community has been dealt a devastating blow from the DEA after the decision was made to add CBDs and cannabis extracts to the Schedule 1 drug category.

Just months ago the DEA made the announcement that they would not be removing cannabis from the Schedule 1 drug category. A Schedule 1 drug is considered to be a “drug or other substance has a high potential for abuse. The drug or other substance has no currently accepted medical treatment use in the U.S.”

The decision to make CBDs and extracts a Schedule 1 comes with unprovoked warning. Especially since CBD’s primary use is for medicinal purposes, namely in the area of preventing seizures in adults and children. The “Establishment of a New Drug Code for Marihuana Extract” reads as follows.

After careful consideration of all comments, the DEA is hereby amending 21 CFR 1308.11(d) to include a new subparagraph (58) which creates a new code number in Schedule I as follows:

“(58) Marihuana Extract—7350
“Meaning an extract containing one or more cannabinoids that has been derived from any plant of the genus Cannabis, other than the separated resin (whether crude or purified) obtained from the plant.”

The creation of this new drug code in the DEA regulations for marihuana extracts allows for more appropriate accounting of such materials consistent with treaty provisions. Such marihuana Start Printed Page 90196extracts remain in Schedule I. Entities registered to handle marihuana (under drug code 7360) that also handle marihuana extracts, will need to apply to modify their registrations to add the new drug code 7350 to their existing DEA registrations and procure quotas specifically for drug code 7350 each year.

Oddly enough, the document spells marijuana as “marihuana” throughout the entire document. Along with the odd spelling, the words marijuana and hemp are not used throughout the entire document, leading some to believe the spelling was intentional to make it harder to search for the new policy if you were looking up “new marijuana policies” for example.

The decision made by the DEA will also impact those licensed to handle cannabis. Anyone licensed to handle cannabis extract is forced to update their paperwork within 30-days of paperwork being released, which is today.

As usual, when these decisions are made by an out of control government the ones that will hurt the most from this decision is the patients in states that have not passed any medicinal cannabis laws.

Many have been ordering CBDs online for the medical benefits and as an alternative to taking highly addictive and dangerous pharmaceuticals. With CBDs now considered a Schedule 1 drug, those days are officially over.

CBD companies will no longer be able to send their products across state lines. People living in states that refuse to move forward with medical cannabis will now have to do without CBDs and extracts, regardless of what medical benefits they were experiencing.

The decision to make CBDs a Schedule 1 drug comes in the middle of the worst opiate crisis America has ever seen. As more people are trying to turn away from pharmaceuticals to try natural medications, the federal government is continuing to make them a less available option.



About Meko Haze

Meko Haze is an independent journalist by day... and an independent journalist by night.

One comment

Leave a Reply